Reporting the role of BCL11A (B-cell lymphoma/leukemia 11A) in malignant solid tumors is rare, but overexpression of BCL11A has been detected in some malignant solid tumors, suggesting that this gene may be a valuable diagnostic and prognostic tool for these tumors (29). Here, BCL11A is linked to cancer.